We are live on ! Find out more
FG

Formula Growth Portfolio holdings

AUM $284M
1-Year Est. Return 54.56%
This Fund
S&P 500
This Quarter Est. Return
+39.63%
1 Year Est. Return
+54.56%
3 Year Est. Return
+117.67%
5 Year Est. Return
+78.26%
10 Year Est. Return
+276.27%
AUM
$284M
AUM Growth
+$62.7M
Cap. Flow
+$6.37M
Cap. Flow %
2.24%
Top 10 Hldgs %
22.84%
Holding
169
New
32
Increased
28
Reduced
43
Closed
24

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$3.23M
2
KVYO icon
Klaviyo
KVYO
+$2.49M
3
GH icon
Guardant Health
GH
+$2.1M
4
EQPT
EquipmentShare.com Inc
EQPT
+$1.66M
5
AVEX
AEVEX Corp
AVEX
+$1.53M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$6.75M
2
NOK icon
Nokia
NOK
+$3.54M
3
FPS
Forgent Power Solutions
FPS
+$2.4M
4
NAVN
Navan Inc
NAVN
+$1.85M
5
ARCB icon
ArcBest
ARCB
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 31.94%
2 Industrials 25.15%
3 Healthcare 16.98%
4 Consumer Discretionary 12.68%
5 Financials 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
1
Micron Technology
MU
$1.05T
$13.9M 4.87%
12,000
-9,000
-43% -$6.75M
SWIM icon
2
Latham Group
SWIM
$833M
$8.9M 3.13%
1,375,082
+120,000
+10% +$674K
SSYS icon
3
Stratasys
SSYS
$678M
$7.36M 2.59%
860,000
+60,000
+8% +$526K
COMP icon
4
Compass
COMP
$8.42B
$6.01M 2.11%
487,300
-80,000
-14% -$666K
ALHC icon
5
Alignment Healthcare
ALHC
$2.83B
$5.27M 1.85%
221,347
-17,861
-7% -$343K
CECO icon
6
Ceco Environmental
CECO
$4.08B
$5.01M 1.76%
55,159
-7,185
-12% -$568K
JHX icon
7
James Hardie Industries
JHX
$17.4B
$4.97M 1.75%
189,765
-47,075
-20% -$1.03M
XPO icon
8
XPO
XPO
$22.1B
$4.72M 1.66%
23,000
KVYO icon
9
Klaviyo
KVYO
$5.74B
$4.53M 1.59%
300,000
+150,000
+100% +$2.49M
ORN icon
10
Orion Group Holdings
ORN
$375M
$4.32M 1.52%
256,633
-41,063
-14% -$567K
CALX icon
11
Calix
CALX
$2.36B
$4.29M 1.51%
115,000
+77,000
+203% +$3.23M
EQPT
12
EquipmentShare.com Inc
EQPT
$4.49B
$4.22M 1.48%
214,523
+77,573
+57% +$1.66M
FOXF icon
13
Fox Factory Holding Corp
FOXF
$864M
$4.11M 1.44%
242,442
-36,764
-13% -$640K
RYAAY icon
14
Ryanair
RYAAY
$29.1B
$4.04M 1.42%
62,388
U icon
15
Unity
U
$19.1B
$4M 1.41%
140,000
+10,000
+8% +$266K
PACK icon
16
Ranpak Holdings
PACK
$420M
$3.82M 1.34%
522,055
-172,472
-25% -$995K
PANW icon
17
Palo Alto Networks
PANW
$303B
$3.73M 1.31%
10,946
MOD icon
18
Modine Manufacturing
MOD
$9.43B
$3.62M 1.27%
13,540
-1,160
-8% -$306K
BTSG icon
19
BrightSpring Health Services
BTSG
$11.7B
$3.51M 1.23%
50,344
-19,334
-28% -$1.07M
ICLR icon
20
Icon
ICLR
$13.1B
$3.25M 1.14%
18,692
+11,692
+167% +$1.49M
RBA icon
21
RB Global
RBA
$15.9B
$3.21M 1.13%
27,604
-104
-0.4% -$10.9K
LIND icon
22
Lindblad Expeditions
LIND
$1.94B
$3.15M 1.11%
111,491
+55,900
+101% +$1.18M
CVSA
23
Covista Inc
CVSA
$4.58B
$3.14M 1.1%
25,196
-108
-0.4% -$13K
UA icon
24
Under Armour Class C
UA
$2.12B
$3.11M 1.09%
500,000
+100,000
+25% +$576K
HQY icon
25
HealthEquity
HQY
$7.97B
$3.11M 1.09%
34,417
-135
-0.4% -$11.4K

Similar funds

Formula Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Formula Growth held 169 positions worth $284M, up 28% from $222M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Formula Growth's Q2 2026 filing shows 32 new, 28 increased, 43 reduced and 24 closed positions. Its largest new stake was Guardant Health: 19,300 shares worth $2.9M. The largest sale was Micron Technology, an estimated $6.75M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Formula Growth's largest Q2 2026 buy was Guardant Health: 19,300 shares worth $2.9M.
  • Formula Growth added most to Calix in Q2 2026, an estimated $3.23M increase.
  • Formula Growth's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $6.75M.
  • Formula Growth fully exited Navan Inc in Q2 2026, selling an estimated $1.85M.
  • Formula Growth's ten largest holdings make up 23% of its $284M portfolio in Q2 2026.
  • Formula Growth opened 32 new positions and closed 24 in Q2 2026.
  • Formula Growth's portfolio value rose 28% quarter-over-quarter to $284M.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.